 David Riches
Concepts (594)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 57 | 2018 | 1478 | 3.170 |
Why?
| | Idiopathic Pulmonary Fibrosis | 11 | 2025 | 629 | 2.540 |
Why?
| | Pulmonary Fibrosis | 16 | 2024 | 384 | 2.300 |
Why?
| | Tumor Necrosis Factor-alpha | 34 | 2014 | 1195 | 2.180 |
Why?
| | Lung | 27 | 2022 | 3916 | 2.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 13 | 2005 | 161 | 2.010 |
Why?
| | Bleomycin | 14 | 2021 | 244 | 1.690 |
Why?
| | Apoptosis | 20 | 2023 | 2501 | 1.570 |
Why?
| | fas Receptor | 7 | 2020 | 95 | 1.440 |
Why?
| | Antigens, CD | 12 | 2004 | 488 | 1.420 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 14 | 2010 | 85 | 1.380 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 11 | 2005 | 184 | 1.240 |
Why?
| | Arthritis, Experimental | 3 | 2018 | 128 | 1.240 |
Why?
| | Signal Transduction | 27 | 2020 | 4913 | 1.220 |
Why?
| | Fibroblasts | 14 | 2025 | 944 | 1.180 |
Why?
| | Macrophages, Alveolar | 10 | 2014 | 389 | 1.130 |
Why?
| | Insulin-Like Growth Factor I | 10 | 2009 | 307 | 1.110 |
Why?
| | Mice | 84 | 2024 | 16861 | 1.100 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 9 | 1999 | 181 | 1.030 |
Why?
| | Mitogen-Activated Protein Kinases | 12 | 2004 | 312 | 1.000 |
Why?
| | Nitric Oxide Synthase | 6 | 2001 | 237 | 0.920 |
Why?
| | Animals | 96 | 2025 | 35219 | 0.920 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 10 | 2002 | 131 | 0.910 |
Why?
| | Mice, Inbred C3H | 30 | 2005 | 273 | 0.840 |
Why?
| | Trans-Activators | 4 | 2015 | 387 | 0.830 |
Why?
| | Lung Injury | 3 | 2019 | 210 | 0.820 |
Why?
| | Interferon-gamma | 14 | 2010 | 769 | 0.780 |
Why?
| | Collagen | 6 | 2018 | 434 | 0.770 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 2 | 2018 | 7 | 0.730 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 11 | 2011 | 161 | 0.730 |
Why?
| | Epithelial Cells | 9 | 2023 | 1064 | 0.720 |
Why?
| | Pulmonary Emphysema | 1 | 2024 | 275 | 0.720 |
Why?
| | TRPC Cation Channels | 2 | 2010 | 13 | 0.710 |
Why?
| | Immunity, Innate | 4 | 2018 | 804 | 0.700 |
Why?
| | Alveolar Epithelial Cells | 5 | 2023 | 106 | 0.650 |
Why?
| | Cells, Cultured | 29 | 2020 | 4072 | 0.650 |
Why?
| | Indoles | 2 | 2019 | 383 | 0.600 |
Why?
| | Macrophage Activation | 11 | 2009 | 188 | 0.600 |
Why?
| | NF-kappa B | 7 | 2009 | 653 | 0.590 |
Why?
| | Pneumonia | 6 | 2018 | 613 | 0.590 |
Why?
| | Myofibroblasts | 1 | 2018 | 121 | 0.550 |
Why?
| | MAP Kinase Kinase 4 | 5 | 2002 | 28 | 0.540 |
Why?
| | Lung Diseases, Interstitial | 4 | 2023 | 601 | 0.530 |
Why?
| | Interleukin-4 | 4 | 2008 | 212 | 0.520 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2024 | 981 | 0.520 |
Why?
| | Cell Line | 16 | 2019 | 2777 | 0.500 |
Why?
| | Lipopolysaccharides | 9 | 2012 | 871 | 0.500 |
Why?
| | Transforming Growth Factor beta | 9 | 2020 | 457 | 0.500 |
Why?
| | Mice, Knockout | 14 | 2020 | 2856 | 0.490 |
Why?
| | Mice, Inbred C57BL | 20 | 2021 | 5408 | 0.480 |
Why?
| | Serum Response Factor | 1 | 2015 | 31 | 0.470 |
Why?
| | TNF Receptor-Associated Factor 2 | 4 | 2010 | 8 | 0.470 |
Why?
| | Monocytes | 7 | 2018 | 551 | 0.460 |
Why?
| | Protein-Tyrosine Kinases | 6 | 1999 | 432 | 0.450 |
Why?
| | Mesoderm | 1 | 2015 | 137 | 0.440 |
Why?
| | Sodium Chloride | 2 | 2006 | 138 | 0.430 |
Why?
| | Interleukin-8 | 6 | 2009 | 262 | 0.430 |
Why?
| | Arthritis, Rheumatoid | 2 | 2013 | 1092 | 0.430 |
Why?
| | Acute Lung Injury | 2 | 2017 | 278 | 0.410 |
Why?
| | Phosphorylation | 16 | 2020 | 1710 | 0.400 |
Why?
| | Bone Marrow Cells | 10 | 2012 | 297 | 0.400 |
Why?
| | Dendritic Cells | 3 | 2013 | 477 | 0.390 |
Why?
| | Disease Models, Animal | 7 | 2020 | 4049 | 0.390 |
Why?
| | Neutrophils | 9 | 2018 | 1202 | 0.380 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2009 | 21 | 0.360 |
Why?
| | Receptor, Muscarinic M1 | 1 | 2010 | 3 | 0.360 |
Why?
| | Lung Diseases | 4 | 2013 | 741 | 0.360 |
Why?
| | beta-Glucans | 5 | 1993 | 27 | 0.350 |
Why?
| | Up-Regulation | 4 | 2012 | 837 | 0.350 |
Why?
| | Phagocytosis | 8 | 2012 | 361 | 0.340 |
Why?
| | Adaptive Immunity | 1 | 2011 | 160 | 0.340 |
Why?
| | RNA, Messenger | 18 | 2011 | 2702 | 0.330 |
Why?
| | Nitric Oxide | 5 | 2010 | 899 | 0.330 |
Why?
| | Enzyme Activation | 13 | 2011 | 811 | 0.330 |
Why?
| | Testosterone | 1 | 2013 | 371 | 0.330 |
Why?
| | X-Ray Microtomography | 2 | 2021 | 84 | 0.320 |
Why?
| | Silicosis | 2 | 2023 | 27 | 0.320 |
Why?
| | Transcription, Genetic | 6 | 2014 | 1415 | 0.320 |
Why?
| | Molecular Sequence Data | 12 | 2010 | 2830 | 0.320 |
Why?
| | Humans | 60 | 2025 | 129212 | 0.320 |
Why?
| | Calcium | 3 | 2010 | 1203 | 0.310 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2011 | 642 | 0.310 |
Why?
| | Lung Compliance | 3 | 2014 | 46 | 0.300 |
Why?
| | Inflammation Mediators | 4 | 2018 | 505 | 0.290 |
Why?
| | Cytokines | 8 | 2018 | 2011 | 0.290 |
Why?
| | Gene Expression Regulation | 8 | 2010 | 2543 | 0.290 |
Why?
| | Poly I-C | 6 | 1994 | 62 | 0.280 |
Why?
| | Inflammation | 8 | 2024 | 2723 | 0.280 |
Why?
| | Interleukin-13 | 2 | 2010 | 147 | 0.280 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 2 | 2020 | 23 | 0.280 |
Why?
| | Autoimmunity | 1 | 2013 | 862 | 0.280 |
Why?
| | Promoter Regions, Genetic | 5 | 2008 | 1206 | 0.280 |
Why?
| | MAP Kinase Kinase Kinase 1 | 2 | 1999 | 19 | 0.280 |
Why?
| | Respiratory Mucosa | 5 | 2025 | 306 | 0.270 |
Why?
| | Chemokines | 2 | 2006 | 225 | 0.270 |
Why?
| | Transcription Factor AP-1 | 2 | 2006 | 85 | 0.270 |
Why?
| | Lysosomes | 6 | 1993 | 138 | 0.260 |
Why?
| | Pulmonary Alveoli | 4 | 2025 | 399 | 0.260 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 182 | 0.260 |
Why?
| | Nitric Oxide Synthase Type II | 7 | 2008 | 171 | 0.250 |
Why?
| | Gene Expression | 5 | 2012 | 1469 | 0.250 |
Why?
| | Membrane Microdomains | 2 | 2004 | 32 | 0.250 |
Why?
| | Th2 Cells | 2 | 2004 | 171 | 0.250 |
Why?
| | Granulomatous Disease, Chronic | 3 | 2010 | 53 | 0.250 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 9 | 2012 | 274 | 0.240 |
Why?
| | Enzyme Induction | 8 | 2008 | 90 | 0.240 |
Why?
| | Male | 28 | 2024 | 63491 | 0.240 |
Why?
| | MAP Kinase Kinase 1 | 6 | 2001 | 76 | 0.230 |
Why?
| | 5' Untranslated Regions | 1 | 2005 | 55 | 0.230 |
Why?
| | Proline | 1 | 2005 | 76 | 0.230 |
Why?
| | Recombinant Proteins | 6 | 2010 | 1303 | 0.230 |
Why?
| | Flow Cytometry | 3 | 2020 | 1156 | 0.230 |
Why?
| | Dual Specificity Phosphatase 1 | 3 | 2012 | 26 | 0.220 |
Why?
| | Keratin-8 | 1 | 2023 | 4 | 0.220 |
Why?
| | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2003 | 4 | 0.220 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2013 | 398 | 0.220 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 2 | 2023 | 232 | 0.210 |
Why?
| | Proteins | 5 | 2004 | 939 | 0.210 |
Why?
| | Precancerous Conditions | 1 | 2004 | 162 | 0.210 |
Why?
| | Growth Substances | 4 | 2004 | 152 | 0.200 |
Why?
| | Stem Cells | 2 | 2019 | 577 | 0.200 |
Why?
| | Adenoma | 1 | 2004 | 212 | 0.200 |
Why?
| | I-kappa B Proteins | 2 | 2012 | 74 | 0.200 |
Why?
| | Respiratory System | 1 | 2024 | 153 | 0.200 |
Why?
| | Endoplasmic Reticulum | 4 | 2011 | 259 | 0.200 |
Why?
| | Female | 24 | 2024 | 68600 | 0.200 |
Why?
| | Complement Factor B | 5 | 1994 | 108 | 0.190 |
Why?
| | Cystic Fibrosis | 4 | 2008 | 1050 | 0.190 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 217 | 0.190 |
Why?
| | Transfection | 4 | 2009 | 908 | 0.190 |
Why?
| | Gene Expression Profiling | 4 | 2020 | 1705 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 246 | 0.190 |
Why?
| | COS Cells | 5 | 2005 | 185 | 0.190 |
Why?
| | Base Sequence | 8 | 2009 | 2141 | 0.180 |
Why?
| | Lymph Nodes | 3 | 2013 | 469 | 0.180 |
Why?
| | Amino Acid Sequence | 5 | 2010 | 2056 | 0.180 |
Why?
| | Mice, Inbred BALB C | 6 | 2012 | 1243 | 0.180 |
Why?
| | Receptors, Cell Surface | 5 | 2009 | 378 | 0.180 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2010 | 361 | 0.180 |
Why?
| | Cell Communication | 2 | 2018 | 300 | 0.180 |
Why?
| | Mice, Mutant Strains | 3 | 2011 | 298 | 0.170 |
Why?
| | Glucans | 6 | 1995 | 34 | 0.170 |
Why?
| | Cell Differentiation | 5 | 2023 | 1899 | 0.170 |
Why?
| | Transcription Factors | 3 | 2011 | 1649 | 0.170 |
Why?
| | Interferon-beta | 4 | 1994 | 89 | 0.170 |
Why?
| | Reference Values | 2 | 2018 | 793 | 0.170 |
Why?
| | Smoke | 2 | 2011 | 140 | 0.170 |
Why?
| | TNF Receptor-Associated Factor 1 | 4 | 2003 | 8 | 0.160 |
Why?
| | MAP Kinase Signaling System | 3 | 2012 | 311 | 0.160 |
Why?
| | Annexin A4 | 1 | 1999 | 6 | 0.160 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 2019 | 24 | 0.160 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 24 | 0.160 |
Why?
| | Cell Survival | 5 | 2013 | 1085 | 0.160 |
Why?
| | Mice, Transgenic | 4 | 2019 | 2111 | 0.160 |
Why?
| | Phosphatidylserines | 4 | 2008 | 88 | 0.160 |
Why?
| | HeLa Cells | 5 | 2013 | 607 | 0.160 |
Why?
| | Fibrosis | 3 | 2019 | 520 | 0.150 |
Why?
| | Drug Resistance, Microbial | 1 | 2018 | 69 | 0.150 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 74 | 0.150 |
Why?
| | Cell Membrane | 4 | 2010 | 730 | 0.150 |
Why?
| | Down-Regulation | 2 | 2018 | 636 | 0.150 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 276 | 0.150 |
Why?
| | Case-Control Studies | 3 | 2018 | 3372 | 0.150 |
Why?
| | Biopsy, Needle | 1 | 2018 | 189 | 0.150 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2001 | 442 | 0.140 |
Why?
| | Cryptogenic Organizing Pneumonia | 1 | 1997 | 19 | 0.140 |
Why?
| | Mycobacterium tuberculosis | 1 | 2001 | 308 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 530 | 0.140 |
Why?
| | Immunohistochemistry | 2 | 2018 | 1696 | 0.140 |
Why?
| | Extracellular Matrix | 3 | 2019 | 503 | 0.140 |
Why?
| | Sex Characteristics | 2 | 2013 | 732 | 0.140 |
Why?
| | Homeostasis | 1 | 2020 | 611 | 0.130 |
Why?
| | Kinetics | 6 | 2004 | 1641 | 0.130 |
Why?
| | Disease Progression | 2 | 2021 | 2622 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2005 | 837 | 0.130 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 584 | 0.130 |
Why?
| | Lung Neoplasms | 2 | 2009 | 2339 | 0.130 |
Why?
| | Nuclear Proteins | 1 | 2001 | 663 | 0.130 |
Why?
| | NADPH Oxidases | 3 | 2010 | 108 | 0.130 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2012 | 832 | 0.120 |
Why?
| | Protein Transport | 4 | 2011 | 425 | 0.120 |
Why?
| | Hydrogels | 1 | 2022 | 638 | 0.120 |
Why?
| | Enzyme Inhibitors | 4 | 2010 | 826 | 0.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 2 | 2006 | 83 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 270 | 0.120 |
Why?
| | Interleukin-10 | 1 | 1997 | 303 | 0.120 |
Why?
| | DNA-Binding Proteins | 4 | 2005 | 1443 | 0.120 |
Why?
| | Permeability | 2 | 2017 | 157 | 0.120 |
Why?
| | Fas Ligand Protein | 2 | 2013 | 58 | 0.120 |
Why?
| | Platelet Activating Factor | 2 | 1995 | 75 | 0.120 |
Why?
| | Blotting, Western | 6 | 2015 | 1205 | 0.120 |
Why?
| | Asbestos | 2 | 1993 | 28 | 0.120 |
Why?
| | Biomarkers | 2 | 2024 | 3968 | 0.110 |
Why?
| | Hyaluronic Acid | 2 | 1994 | 213 | 0.110 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2009 | 312 | 0.110 |
Why?
| | Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 9 | 0.110 |
Why?
| | Hydroxyproline | 1 | 2014 | 21 | 0.110 |
Why?
| | Binding Sites | 2 | 2010 | 1249 | 0.110 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2014 | 26 | 0.110 |
Why?
| | Sequence Deletion | 2 | 2005 | 178 | 0.110 |
Why?
| | Receptors, Immunologic | 2 | 2015 | 216 | 0.110 |
Why?
| | Risk Factors | 3 | 2024 | 9747 | 0.110 |
Why?
| | Fas-Associated Death Domain Protein | 2 | 2005 | 9 | 0.110 |
Why?
| | Consensus Sequence | 2 | 2005 | 72 | 0.110 |
Why?
| | Interferons | 2 | 1998 | 194 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2009 | 431 | 0.110 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 1993 | 16 | 0.110 |
Why?
| | Endocytosis | 2 | 2011 | 163 | 0.110 |
Why?
| | Bronchiolitis Obliterans | 1 | 1994 | 68 | 0.110 |
Why?
| | Extracellular Vesicles | 1 | 2015 | 130 | 0.110 |
Why?
| | Remission Induction | 1 | 2014 | 269 | 0.110 |
Why?
| | Fibronectins | 1 | 1994 | 122 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 3 | 2004 | 637 | 0.100 |
Why?
| | Proteolysis | 1 | 2013 | 165 | 0.100 |
Why?
| | Chemokine CXCL1 | 2 | 2011 | 73 | 0.100 |
Why?
| | Cytoplasm | 2 | 2005 | 263 | 0.100 |
Why?
| | Drug Synergism | 3 | 2003 | 369 | 0.100 |
Why?
| | Protein Kinase C | 1 | 1994 | 259 | 0.100 |
Why?
| | Anthrax | 1 | 2012 | 9 | 0.100 |
Why?
| | Bacillus anthracis | 1 | 2012 | 12 | 0.100 |
Why?
| | Transcriptional Activation | 2 | 2005 | 365 | 0.100 |
Why?
| | Cell Lineage | 1 | 2013 | 333 | 0.100 |
Why?
| | Delayed-Action Preparations | 1 | 2012 | 173 | 0.090 |
Why?
| | GTPase-Activating Proteins | 1 | 2012 | 81 | 0.090 |
Why?
| | Matrix Metalloproteinase 3 | 1 | 2011 | 26 | 0.090 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 57 | 0.090 |
Why?
| | Receptors, Lipoprotein | 1 | 1991 | 4 | 0.090 |
Why?
| | Autophagy | 1 | 2013 | 267 | 0.090 |
Why?
| | Pyridones | 1 | 2012 | 158 | 0.090 |
Why?
| | Okadaic Acid | 2 | 2001 | 14 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 141 | 0.090 |
Why?
| | Microscopy, Electron | 3 | 2015 | 425 | 0.090 |
Why?
| | Trauma Severity Indices | 1 | 2011 | 104 | 0.090 |
Why?
| | Wound Healing | 2 | 2017 | 303 | 0.090 |
Why?
| | Oxidative Stress | 3 | 2015 | 1268 | 0.090 |
Why?
| | Leukotrienes | 1 | 1991 | 37 | 0.090 |
Why?
| | Peritonitis | 2 | 2010 | 81 | 0.090 |
Why?
| | Polymerase Chain Reaction | 4 | 2012 | 1036 | 0.090 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 67 | 0.090 |
Why?
| | Receptors, IgG | 3 | 2009 | 74 | 0.090 |
Why?
| | Chemokine CXCL2 | 2 | 2010 | 43 | 0.090 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2011 | 101 | 0.090 |
Why?
| | Cloning, Molecular | 2 | 2003 | 524 | 0.090 |
Why?
| | Lipoproteins, LDL | 1 | 1991 | 127 | 0.090 |
Why?
| | Schistosoma mansoni | 1 | 2010 | 37 | 0.090 |
Why?
| | Antigen Presentation | 1 | 2011 | 206 | 0.080 |
Why?
| | Protein Binding | 5 | 2013 | 2119 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 151 | 0.080 |
Why?
| | Schistosomiasis | 1 | 2010 | 47 | 0.080 |
Why?
| | Recovery of Function | 1 | 2014 | 640 | 0.080 |
Why?
| | Granuloma | 1 | 2010 | 89 | 0.080 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 146 | 0.080 |
Why?
| | Nitrites | 2 | 2001 | 83 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2017 | 2388 | 0.080 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 336 | 0.080 |
Why?
| | Thiazolidinediones | 1 | 2010 | 137 | 0.080 |
Why?
| | NIH 3T3 Cells | 2 | 2014 | 141 | 0.080 |
Why?
| | Mitochondria | 1 | 2015 | 875 | 0.080 |
Why?
| | Antigens | 1 | 2011 | 355 | 0.080 |
Why?
| | PPAR gamma | 1 | 2010 | 183 | 0.080 |
Why?
| | Elastin | 1 | 2009 | 77 | 0.080 |
Why?
| | MicroRNAs | 1 | 2015 | 675 | 0.080 |
Why?
| | Intubation, Intratracheal | 1 | 2011 | 238 | 0.080 |
Why?
| | Drug Delivery Systems | 1 | 2012 | 335 | 0.080 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2009 | 126 | 0.080 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 168 | 0.080 |
Why?
| | Myoblasts | 1 | 2009 | 81 | 0.080 |
Why?
| | DEAD-box RNA Helicases | 1 | 2009 | 65 | 0.070 |
Why?
| | Nanoparticles | 1 | 2012 | 373 | 0.070 |
Why?
| | Protein Processing, Post-Translational | 2 | 2005 | 454 | 0.070 |
Why?
| | Vitamin D | 1 | 2012 | 383 | 0.070 |
Why?
| | Time Factors | 3 | 2014 | 6549 | 0.070 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 2001 | 149 | 0.070 |
Why?
| | Interleukin-1 | 3 | 2001 | 958 | 0.070 |
Why?
| | Superoxide Dismutase | 1 | 2010 | 342 | 0.070 |
Why?
| | Glucocorticoids | 2 | 2012 | 574 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 249 | 0.070 |
Why?
| | Respiration, Artificial | 1 | 2012 | 609 | 0.070 |
Why?
| | Prednisone | 1 | 2008 | 232 | 0.070 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2008 | 67 | 0.070 |
Why?
| | Interleukin-1beta | 1 | 2009 | 372 | 0.070 |
Why?
| | Interferon Type I | 1 | 1988 | 139 | 0.070 |
Why?
| | Asthma | 2 | 2012 | 2222 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 2 | 1998 | 41 | 0.070 |
Why?
| | Genes, Reporter | 2 | 2014 | 266 | 0.070 |
Why?
| | Models, Biological | 2 | 2013 | 1718 | 0.070 |
Why?
| | Middle Aged | 8 | 2012 | 31075 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 2 | 2019 | 478 | 0.070 |
Why?
| | Chromatography, Ion Exchange | 2 | 1997 | 52 | 0.070 |
Why?
| | Survival Rate | 1 | 2011 | 1874 | 0.070 |
Why?
| | B-Lymphocytes | 1 | 2012 | 815 | 0.070 |
Why?
| | Genetic Vectors | 2 | 2011 | 312 | 0.060 |
Why?
| | Vaccines | 1 | 2011 | 397 | 0.060 |
Why?
| | Glucuronidase | 3 | 1993 | 44 | 0.060 |
Why?
| | Adenine Nucleotides | 1 | 1985 | 22 | 0.060 |
Why?
| | Sex Factors | 1 | 2011 | 1961 | 0.060 |
Why?
| | Metalloendopeptidases | 1 | 2005 | 59 | 0.060 |
Why?
| | Asparagine | 1 | 2005 | 30 | 0.060 |
Why?
| | Sp3 Transcription Factor | 1 | 2005 | 5 | 0.060 |
Why?
| | Bronchoalveolar Lavage | 2 | 2012 | 91 | 0.060 |
Why?
| | Bone Marrow | 3 | 2004 | 270 | 0.060 |
Why?
| | Antibodies | 2 | 1998 | 397 | 0.060 |
Why?
| | Colorado | 1 | 2015 | 4412 | 0.060 |
Why?
| | Golgi Apparatus | 2 | 2005 | 99 | 0.060 |
Why?
| | Luciferases | 1 | 2005 | 148 | 0.060 |
Why?
| | Serine | 1 | 2005 | 137 | 0.060 |
Why?
| | Membrane Proteins | 1 | 1991 | 1115 | 0.060 |
Why?
| | Dinoprostone | 3 | 1995 | 186 | 0.060 |
Why?
| | Antibodies, Monoclonal | 4 | 1999 | 1364 | 0.060 |
Why?
| | Point Mutation | 1 | 2005 | 225 | 0.060 |
Why?
| | Culture Media, Conditioned | 1 | 2004 | 110 | 0.060 |
Why?
| | Hyperplasia | 1 | 2004 | 171 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2005 | 282 | 0.060 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2004 | 123 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 2 | 2013 | 643 | 0.060 |
Why?
| | Phenotype | 4 | 2019 | 3074 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 958 | 0.060 |
Why?
| | rac GTP-Binding Proteins | 1 | 2004 | 32 | 0.060 |
Why?
| | TNF Receptor-Associated Death Domain Protein | 1 | 2003 | 2 | 0.060 |
Why?
| | CD36 Antigens | 1 | 2004 | 36 | 0.060 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2003 | 14 | 0.050 |
Why?
| | Age Factors | 1 | 2011 | 3137 | 0.050 |
Why?
| | Actins | 4 | 2009 | 408 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2713 | 0.050 |
Why?
| | STAT6 Transcription Factor | 1 | 2003 | 26 | 0.050 |
Why?
| | Exons | 1 | 2005 | 342 | 0.050 |
Why?
| | Blood Proteins | 2 | 2001 | 242 | 0.050 |
Why?
| | STAT1 Transcription Factor | 1 | 2003 | 70 | 0.050 |
Why?
| | In Vitro Techniques | 3 | 1991 | 1083 | 0.050 |
Why?
| | Platelet-Derived Growth Factor | 2 | 1993 | 89 | 0.050 |
Why?
| | Calcimycin | 2 | 1994 | 49 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2003 | 111 | 0.050 |
Why?
| | Chromones | 1 | 2002 | 45 | 0.050 |
Why?
| | Thorax | 1 | 2022 | 41 | 0.050 |
Why?
| | Osmotic Pressure | 1 | 2002 | 35 | 0.050 |
Why?
| | Microscopy, Fluorescence | 2 | 2004 | 400 | 0.050 |
Why?
| | Flavonoids | 1 | 2002 | 78 | 0.050 |
Why?
| | Phosphoamino Acids | 1 | 2001 | 1 | 0.050 |
Why?
| | Adenoviridae | 2 | 2014 | 192 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2001 | 5 | 0.050 |
Why?
| | Beclomethasone | 1 | 2001 | 27 | 0.050 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2001 | 29 | 0.050 |
Why?
| | Morpholines | 1 | 2002 | 122 | 0.050 |
Why?
| | Adrenal Glands | 1 | 2001 | 70 | 0.050 |
Why?
| | Aged | 4 | 2009 | 22030 | 0.050 |
Why?
| | MAP Kinase Kinase 7 | 1 | 2001 | 7 | 0.050 |
Why?
| | Jurkat Cells | 2 | 2013 | 133 | 0.050 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2001 | 49 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2009 | 2071 | 0.050 |
Why?
| | Genes, bcl-2 | 1 | 2001 | 21 | 0.050 |
Why?
| | Caspase 8 | 1 | 2001 | 48 | 0.050 |
Why?
| | Genes, Dominant | 1 | 2001 | 92 | 0.050 |
Why?
| | Caspase 9 | 1 | 2001 | 55 | 0.040 |
Why?
| | Rats | 3 | 2017 | 5462 | 0.040 |
Why?
| | In Situ Nick-End Labeling | 1 | 2001 | 124 | 0.040 |
Why?
| | Prospective Studies | 2 | 2011 | 7103 | 0.040 |
Why?
| | Gene Deletion | 2 | 2014 | 378 | 0.040 |
Why?
| | Mutation | 3 | 2004 | 3715 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2281 | 0.040 |
Why?
| | Acetylcysteine | 1 | 2001 | 146 | 0.040 |
Why?
| | Phosphopeptides | 1 | 2000 | 18 | 0.040 |
Why?
| | Peptide Mapping | 1 | 2000 | 63 | 0.040 |
Why?
| | Hydrolases | 2 | 1993 | 56 | 0.040 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2000 | 67 | 0.040 |
Why?
| | Protein Phosphatase 2 | 1 | 2000 | 38 | 0.040 |
Why?
| | Adult | 8 | 2012 | 35464 | 0.040 |
Why?
| | Imidazoles | 1 | 2001 | 234 | 0.040 |
Why?
| | Caspases | 1 | 2001 | 245 | 0.040 |
Why?
| | NADPH Oxidase 2 | 2 | 2010 | 38 | 0.040 |
Why?
| | Immunoblotting | 2 | 2001 | 304 | 0.040 |
Why?
| | Molecular Weight | 1 | 2000 | 331 | 0.040 |
Why?
| | Obesity | 1 | 2012 | 2876 | 0.040 |
Why?
| | Sepharose | 1 | 1999 | 33 | 0.040 |
Why?
| | Alkaline Phosphatase | 1 | 2000 | 145 | 0.040 |
Why?
| | Nitrobenzoates | 1 | 1998 | 1 | 0.040 |
Why?
| | Substrate Specificity | 1 | 2000 | 368 | 0.040 |
Why?
| | Indomethacin | 2 | 1991 | 78 | 0.040 |
Why?
| | 3T3 Cells | 1 | 1999 | 151 | 0.040 |
Why?
| | DNA, Complementary | 1 | 1999 | 270 | 0.040 |
Why?
| | Scleroderma, Systemic | 1 | 2019 | 108 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2001 | 545 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2010 | 1891 | 0.040 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 1998 | 60 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 371 | 0.040 |
Why?
| | Dexamethasone | 2 | 2012 | 346 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 768 | 0.040 |
Why?
| | MAP Kinase Kinase 3 | 1 | 1997 | 7 | 0.040 |
Why?
| | Chemotactic Factors | 1 | 1998 | 54 | 0.040 |
Why?
| | Chemokines, CXC | 1 | 1998 | 69 | 0.040 |
Why?
| | DNA Probes | 1 | 1997 | 61 | 0.040 |
Why?
| | Adaptation, Physiological | 2 | 1995 | 511 | 0.040 |
Why?
| | Phospholipids | 1 | 1999 | 215 | 0.040 |
Why?
| | Interleukin-6 | 2 | 2008 | 720 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2001 | 387 | 0.040 |
Why?
| | Regeneration | 1 | 2019 | 179 | 0.030 |
Why?
| | Drug Interactions | 1 | 1998 | 390 | 0.030 |
Why?
| | Pyridines | 1 | 2001 | 478 | 0.030 |
Why?
| | Reactive Oxygen Species | 2 | 2010 | 595 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2017 | 79 | 0.030 |
Why?
| | Cilia | 1 | 1998 | 178 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 83 | 0.030 |
Why?
| | Membrane Glycoproteins | 2 | 2010 | 473 | 0.030 |
Why?
| | Cell Division | 1 | 1998 | 796 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2001 | 740 | 0.030 |
Why?
| | Catalysis | 1 | 1997 | 308 | 0.030 |
Why?
| | Blotting, Northern | 2 | 1998 | 200 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2012 | 2387 | 0.030 |
Why?
| | Complement C3 | 2 | 1988 | 203 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 1998 | 375 | 0.030 |
Why?
| | Arrestins | 1 | 2015 | 14 | 0.030 |
Why?
| | Receptor Aggregation | 1 | 1995 | 10 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2015 | 31 | 0.030 |
Why?
| | Cell Movement | 2 | 2013 | 941 | 0.030 |
Why?
| | Lymphocytes | 1 | 1997 | 373 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1995 | 45 | 0.030 |
Why?
| | Pancreatic Elastase | 1 | 1995 | 60 | 0.030 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2015 | 96 | 0.030 |
Why?
| | Leukocyte Elastase | 1 | 1995 | 74 | 0.030 |
Why?
| | Protein Kinases | 1 | 1997 | 318 | 0.030 |
Why?
| | Regression Analysis | 1 | 1997 | 993 | 0.030 |
Why?
| | Eosinophils | 1 | 1997 | 323 | 0.030 |
Why?
| | Toll-Like Receptors | 1 | 2015 | 179 | 0.030 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 67 | 0.030 |
Why?
| | Exosomes | 1 | 2015 | 96 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2017 | 527 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2022 | 2736 | 0.030 |
Why?
| | Leukocyte Count | 1 | 1995 | 325 | 0.030 |
Why?
| | Smad Proteins | 1 | 2014 | 38 | 0.030 |
Why?
| | Sequestosome-1 Protein | 1 | 2013 | 13 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2014 | 56 | 0.030 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 1995 | 206 | 0.030 |
Why?
| | Forecasting | 1 | 1995 | 358 | 0.030 |
Why?
| | alpha 1-Antitrypsin | 1 | 1995 | 107 | 0.030 |
Why?
| | Chloroquine | 1 | 2013 | 52 | 0.030 |
Why?
| | beta-N-Acetylhexosaminidases | 2 | 1991 | 11 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2010 | 1285 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2013 | 44 | 0.030 |
Why?
| | Eicosanoids | 1 | 1993 | 57 | 0.030 |
Why?
| | Macrophages, Peritoneal | 1 | 1993 | 91 | 0.030 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 263 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 889 | 0.030 |
Why?
| | Culture Media | 1 | 2013 | 162 | 0.030 |
Why?
| | Zymosan | 2 | 2010 | 65 | 0.030 |
Why?
| | Polyglactin 910 | 1 | 2012 | 6 | 0.030 |
Why?
| | PPAR delta | 1 | 2012 | 5 | 0.030 |
Why?
| | Endothelium | 1 | 2013 | 120 | 0.030 |
Why?
| | Isoenzymes | 1 | 1994 | 302 | 0.030 |
Why?
| | Receptors, Chemokine | 1 | 2012 | 45 | 0.030 |
Why?
| | Cyclooxygenase 2 | 1 | 2013 | 177 | 0.030 |
Why?
| | Young Adult | 1 | 2009 | 12396 | 0.030 |
Why?
| | Spores, Bacterial | 1 | 2012 | 17 | 0.020 |
Why?
| | Receptors, CCR7 | 1 | 2012 | 27 | 0.020 |
Why?
| | Diterpenes | 1 | 2012 | 32 | 0.020 |
Why?
| | Ionomycin | 1 | 1992 | 24 | 0.020 |
Why?
| | Prone Position | 1 | 2012 | 30 | 0.020 |
Why?
| | Supine Position | 1 | 2012 | 38 | 0.020 |
Why?
| | Cell Separation | 1 | 1993 | 316 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 3627 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2013 | 385 | 0.020 |
Why?
| | Berylliosis | 1 | 1994 | 185 | 0.020 |
Why?
| | Immunophenotyping | 1 | 1993 | 311 | 0.020 |
Why?
| | Autoradiography | 1 | 1991 | 73 | 0.020 |
Why?
| | Anions | 1 | 1991 | 31 | 0.020 |
Why?
| | Sarcoidosis | 1 | 1994 | 155 | 0.020 |
Why?
| | Adolescent | 2 | 2009 | 20371 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 86 | 0.020 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 362 | 0.020 |
Why?
| | Caspase 12 | 1 | 2011 | 1 | 0.020 |
Why?
| | Aldehydes | 1 | 2012 | 143 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2012 | 131 | 0.020 |
Why?
| | Thapsigargin | 1 | 2011 | 19 | 0.020 |
Why?
| | Staurosporine | 1 | 2011 | 20 | 0.020 |
Why?
| | Receptors, Complement | 1 | 2012 | 122 | 0.020 |
Why?
| | Instillation, Drug | 1 | 2011 | 10 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2011 | 63 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2011 | 55 | 0.020 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2012 | 126 | 0.020 |
Why?
| | 5,8,11,14-Eicosatetraynoic Acid | 1 | 1991 | 4 | 0.020 |
Why?
| | Asbestos, Serpentine | 1 | 1991 | 5 | 0.020 |
Why?
| | SRS-A | 1 | 1991 | 30 | 0.020 |
Why?
| | Receptors, Glucocorticoid | 1 | 2012 | 147 | 0.020 |
Why?
| | Phospholipases A2 | 1 | 1991 | 79 | 0.020 |
Why?
| | Scavenger Receptors, Class B | 1 | 1991 | 11 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 1991 | 406 | 0.020 |
Why?
| | Calcium Channel Blockers | 1 | 1992 | 159 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 119 | 0.020 |
Why?
| | Receptors, Scavenger | 1 | 1991 | 21 | 0.020 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1991 | 38 | 0.020 |
Why?
| | Cell Fractionation | 1 | 1990 | 56 | 0.020 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1991 | 80 | 0.020 |
Why?
| | Onium Compounds | 1 | 2010 | 11 | 0.020 |
Why?
| | Cell Compartmentation | 1 | 1990 | 52 | 0.020 |
Why?
| | Phospholipases A | 1 | 1991 | 99 | 0.020 |
Why?
| | Phagosomes | 1 | 1990 | 42 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 1990 | 81 | 0.020 |
Why?
| | Benzoquinones | 1 | 1991 | 47 | 0.020 |
Why?
| | Immunoglobulin M | 1 | 2012 | 275 | 0.020 |
Why?
| | Sputum | 1 | 2012 | 301 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 1990 | 83 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2010 | 43 | 0.020 |
Why?
| | Smad2 Protein | 1 | 2010 | 38 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 287 | 0.020 |
Why?
| | Endomyocardial Fibrosis | 1 | 2009 | 3 | 0.020 |
Why?
| | Cadherins | 1 | 2011 | 188 | 0.020 |
Why?
| | Janus Kinase 2 | 1 | 2009 | 32 | 0.020 |
Why?
| | Ventricular Pressure | 1 | 2009 | 44 | 0.020 |
Why?
| | Stress Fibers | 1 | 2009 | 18 | 0.020 |
Why?
| | Amiloride | 1 | 2009 | 24 | 0.020 |
Why?
| | STAT5 Transcription Factor | 1 | 2009 | 48 | 0.020 |
Why?
| | beta Catenin | 1 | 2011 | 220 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2001 | 2003 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2011 | 202 | 0.020 |
Why?
| | Survivors | 1 | 2013 | 463 | 0.020 |
Why?
| | Viral Load | 1 | 2011 | 448 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 213 | 0.020 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2009 | 15 | 0.020 |
Why?
| | RNA Splice Sites | 1 | 2009 | 44 | 0.020 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2009 | 89 | 0.020 |
Why?
| | Codon, Nonsense | 1 | 2009 | 39 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2009 | 376 | 0.020 |
Why?
| | Receptors, Interleukin-1 | 1 | 2009 | 218 | 0.020 |
Why?
| | Skin | 1 | 2013 | 721 | 0.020 |
Why?
| | Immune Sera | 1 | 1988 | 86 | 0.020 |
Why?
| | Neutralization Tests | 1 | 1988 | 73 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2009 | 257 | 0.020 |
Why?
| | Drug Resistance | 1 | 2008 | 166 | 0.020 |
Why?
| | Gene Frequency | 1 | 2009 | 503 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2009 | 465 | 0.020 |
Why?
| | Acid Phosphatase | 1 | 1986 | 20 | 0.020 |
Why?
| | Hexosaminidases | 1 | 1986 | 18 | 0.020 |
Why?
| | Risk | 1 | 2009 | 854 | 0.020 |
Why?
| | Methylamines | 1 | 1986 | 30 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2009 | 778 | 0.020 |
Why?
| | COP-Coated Vesicles | 1 | 2005 | 2 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1986 | 137 | 0.020 |
Why?
| | Tubercidin | 1 | 1985 | 2 | 0.020 |
Why?
| | Secretory Rate | 1 | 1985 | 18 | 0.020 |
Why?
| | Esterases | 1 | 1985 | 15 | 0.020 |
Why?
| | ADAM17 Protein | 1 | 2005 | 33 | 0.020 |
Why?
| | Threonine | 1 | 2005 | 44 | 0.020 |
Why?
| | Receptors, Purinergic | 1 | 1985 | 23 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2009 | 496 | 0.020 |
Why?
| | ADAM Proteins | 1 | 2005 | 59 | 0.010 |
Why?
| | Theophylline | 1 | 1985 | 68 | 0.010 |
Why?
| | Homocysteine | 1 | 1985 | 152 | 0.010 |
Why?
| | T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2004 | 2 | 0.010 |
Why?
| | Guanine Nucleotides | 1 | 2004 | 15 | 0.010 |
Why?
| | Cell Surface Extensions | 1 | 2004 | 12 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1985 | 548 | 0.010 |
Why?
| | Cell Size | 1 | 2004 | 89 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1986 | 401 | 0.010 |
Why?
| | Erythrocytes | 1 | 2009 | 672 | 0.010 |
Why?
| | Genetic Variation | 1 | 2009 | 937 | 0.010 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2004 | 54 | 0.010 |
Why?
| | Infant, Newborn | 1 | 1995 | 5753 | 0.010 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2004 | 63 | 0.010 |
Why?
| | Adenosine | 1 | 1985 | 224 | 0.010 |
Why?
| | Adenine | 1 | 1985 | 256 | 0.010 |
Why?
| | Cytoskeleton | 1 | 2004 | 182 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 5408 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2009 | 1332 | 0.010 |
Why?
| | Airway Resistance | 1 | 2001 | 38 | 0.010 |
Why?
| | Microtubules | 1 | 2004 | 262 | 0.010 |
Why?
| | Nebulizers and Vaporizers | 1 | 2001 | 83 | 0.010 |
Why?
| | Quality of Life | 1 | 2013 | 2693 | 0.010 |
Why?
| | Infant | 1 | 1995 | 9016 | 0.010 |
Why?
| | Probability | 1 | 2001 | 306 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 329 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2001 | 421 | 0.010 |
Why?
| | Bronchoscopy | 1 | 2001 | 211 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2001 | 665 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2001 | 767 | 0.010 |
Why?
| | Glucan Endo-1,3-beta-D-Glucosidase | 1 | 1998 | 1 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2001 | 1026 | 0.010 |
Why?
| | Pilot Projects | 1 | 2001 | 1584 | 0.010 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 1995 | 35 | 0.010 |
Why?
| | Bucladesine | 1 | 1995 | 25 | 0.010 |
Why?
| | Dactinomycin | 1 | 1995 | 28 | 0.010 |
Why?
| | Cycloheximide | 1 | 1995 | 56 | 0.010 |
Why?
| | Child | 2 | 2008 | 20853 | 0.010 |
Why?
| | Peritoneal Lavage | 1 | 1993 | 7 | 0.010 |
Why?
| | Leukotriene C4 | 1 | 1993 | 11 | 0.010 |
Why?
| | Diamide | 1 | 1993 | 5 | 0.010 |
Why?
| | Rosette Formation | 1 | 1993 | 16 | 0.010 |
Why?
| | Arachidonic Acid | 1 | 1993 | 115 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1993 | 188 | 0.010 |
Why?
| | DNA Primers | 1 | 1994 | 510 | 0.010 |
Why?
| | Epoprostenol | 1 | 1993 | 136 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2001 | 4886 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 1993 | 381 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2001 | 10189 | 0.000 |
Why?
| | Child, Preschool | 1 | 2001 | 10507 | 0.000 |
Why?
| | Mannans | 1 | 1986 | 6 | 0.000 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1986 | 119 | 0.000 |
Why?
|
|
Riches's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|